Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-042361

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 11, 2015P98,700$18.04A2,200,247IBy LP
Common StockF1May 12, 2015P44,400$18.2514A2,244,647IBy LP
Common StockF1May 13, 2015P47,483$18.6284A2,292,130IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses